P073-0633 Screening compound: (2E)-N-(2-{1-[(4-fluorophenyl)methyl]-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)-3-(furan-2-yl)prop-2-enamide

P073-0633 Screening compound: (2E)-N-(2-{1-[(4-fluorophenyl)methyl]-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)-3-(furan-2-yl)prop-2-enamide
P073-0633 Screening compound: (2E)-N-(2-{1-[(4-fluorophenyl)methyl]-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)-3-(furan-2-yl)prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P073-0633
(2E)-N-(2-{1-[(4-fluorophenyl)methyl]-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)-3-(furan-2-yl)prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P073-0633

Molecular Formula

C22H19FN4O3 (C22 H19 FN4 O3)

Compound Name

(2E)-N-(2-{1-[(4-fluorophenyl)methyl]-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)-3-(furan-2-yl)prop-2-enamide

IUPAC name

(2E)-N-(2-{1-[(4-fluorophenyl)methyl]-2-oxo-1H2H3H-imidazo[45-b]pyridin-3-yl}ethyl)-3-(furan-2-yl)prop-2-enamide

SMILES

O=C(/C=C/c1ccco1)NCCN(c(nccc1)c1N1Cc(cc2)ccc2F)C1=O

InChI

InChI=1S/C22H19FN4O3/c23-17-7-5-16(6-8-17)15-27-19-4-1-11-25-21(19)26(22(27)29)13-12-24-20(28)10-9-18-3-2-14-30-18/h1-11,14H,12-13,15H2,(H,24,28)

InChI Key

GZEFIICVIXKOKQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27562521

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

406.42

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.531

Distribution Coefficient, logD

3.531

Water Solubility, LogSw

-3.50

Polar Surface Area

60.220

Acid Dissociation Constant (pKa)

14.98

Base Dissociation Constant (pKb)

3.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.60

P073-0633 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with P073-0633 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P073-0633?
Check Price and Availability of P073-0633, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P073-0633 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P073-0633
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P073-0633
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P073-0633 available by request